Last reviewed · How we verify

NCT03884140

Clinical Diagnostic Approach for Cases of Thyroid Nodules

Status unknown Last updated 27 June 2019
What this trial tests

trial in Thyroid Nodule in 1 participant. Status unknown.

Timeline
1 September 2019
Primary endpoint
1 June 2022
1 September 2022

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1
Start date1 September 2019
Primary completion1 June 2022
Estimated completion1 September 2022

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 75, any sex, with Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thyroid nodules are a common presentation in the clinic, with an increasing incidence, especially in women. Their clinical significance is mainly related to excluding malignancy (4.0 to 6.5% of all thyroid nodules).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Thyroid Nodule

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03884140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing